Viking Therapeutics (VKTX) Short-term Investments (2015 - 2026)
Viking Therapeutics (VKTX) reported Short-term Investments of $375.91 million for Q2 2026, down 51.4% from $773.84 million a year earlier and down 22.5% from the prior quarter.
Powered by 
Analysis
Viking Therapeutics (VKTX) Short-term Investments (2015 - 2026) Analysis & Trends
At the end of FY2025, Viking Therapeutics posted Short-term Investments of $539.93 million, down 38.4% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of 19.7% (FY2020 to FY2025).
- By year, Short-term Investments came in at $875.94 million in FY2024 (+185.7%), $306.56 million in FY2023 (+157.9%), $118.85 million in FY2022 (-32.4%) and $175.73 million in FY2021 (-19.9%).
- The Q2 2026 figure ranks as the lowest quarterly Short-term Investments since Q4 2023.
- Year over year, Short-term Investments has now declined in each of the last five quarters, with growth averaging 22.1% over the last eight quarters.
- The high point for year-over-year Short-term Investments in five years was Q1 2024 (growth of 554.2%); the low point was Q2 2026 (a decline of 51.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $484.85 million (Q1 2026), $539.93 million (Q4 2025) and $614.19 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn |
| 10 | Viking Therapeutics | 3.01 Bn | 488.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 375.91 Mn |
| Mar 31, 2026 | 484.85 Mn |
| Dec 31, 2025 | 539.93 Mn |
| Sep 30, 2025 | 614.19 Mn |
| Jun 30, 2025 | 773.84 Mn |
| Mar 31, 2025 | 813.92 Mn |
| Dec 31, 2024 | 875.94 Mn |
| Sep 30, 2024 | 880.09 Mn |
| Jun 30, 2024 | 898.35 Mn |
| Mar 31, 2024 | 767.40 Mn |
| Dec 31, 2023 | 306.56 Mn |
| Sep 30, 2023 | 339.06 Mn |
| Jun 30, 2023 | 323.40 Mn |
| Mar 31, 2023 | 117.30 Mn |
| Dec 31, 2022 | 118.85 Mn |
| Sep 30, 2022 | 125.62 Mn |
| Jun 30, 2022 | 152.69 Mn |
| Mar 31, 2022 | 172.45 Mn |
| Dec 31, 2021 | 175.73 Mn |
| Sep 30, 2021 | 204.87 Mn |
API Access
Viking Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=VKTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "VKTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=VKTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();